Company Filing History:
Years Active: 1995
Title: Innovations by Harald Forster
Introduction
Harald Forster is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of medical technology, particularly in the development of blood plasma substitutes and pharmaceutical compositions for peritoneal dialysis. With a total of 2 patents, Forster's work has the potential to impact patient care and treatment options.
Latest Patents
Forster's latest patents include a metabolizable plasma substitute and a pharmaceutical composition for peritoneal dialysis. The metabolizable blood plasma substitute is designed to contain a starch ester with a molecular weight (Mw) of >20000 Daltons and a molar substitution of 0.1 to 1.5 as a colloidal component. Specifically, the starch ester can be acetyl starch with a molecular weight ranging from 200000 to 230000 Daltons and a molar substitution of 0.3 to 0.5. The second patent focuses on a pharmaceutical composition that utilizes a starch ester for continuous ambulatory peritoneal dialysis (CAPD). This composition is particularly beneficial as it allows for peritoneal dialysis without damaging the peritoneal epithelium and ensures that the starch ester is not stored in the organs.
Career Highlights
Forster is associated with Laevosan-Gesellschaft M.b.h., where he continues to innovate in the medical field. His work is characterized by a commitment to improving patient outcomes through advanced medical solutions.
Collaborations
Forster collaborates with talented individuals such as Fatima Asskali and Ernst Nitsch, contributing to a dynamic and innovative work environment.
Conclusion
Harald Forster's contributions to medical technology through his patents demonstrate his dedication to enhancing healthcare solutions. His innovative work in blood plasma substitutes and peritoneal dialysis compositions showcases the potential for significant advancements in patient care.